Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N vs Custodiol in CABG
NCT01444235Phase 2Completed
- Sponsor
- Franz Köhler Chemie
- Start
- Mar 2011
- Primary completion
- May 2012
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of histidine-tryptophan-ketoglutarate solution (modified) in coronary artery disease (CAD), sponsored by Franz Köhler Chemie. Started Mar 2011; status: completed.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01444235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444235.